![](https://investorshub.advfn.com/uicon/591374.png?cb=1485035485)
Friday, January 20, 2017 6:26:14 PM
Look at TSRO. It's a typical big board biotech company that has raised and burns through millions of dollars, yet has a value of $7 Billion.
Perhaps OWCP should have listed on the NYSE, maybe they even tried. But years ago no one in their right mind would have underwritten millions for a MMJ company.
That's the other thing you might be over looking. OWCP is YEARS ahead of the competition in research.
OWCP could get snatched up in a heartbeat by a company like Teva. OWCP has patents covering a sublingual tablet for CBD/THC medicines. They will license that to other companies and that will generate millions of dollars of revenue every quarter. And unlike medicines which eventually go generic, OWCPs delivery platform patentS (cream, sublingual tablet, nasal spray) will derive revenue forever.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM